Clinical Trials List
Protocol Number00103311
Completed
2014-04-01 - 2018-06-30
Phase III
Terminated3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HSIN-AN HOU Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
400 participants
